Alzheimer’s prevention hope as drug cuts deadly disease onset in half
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in people with a genetic predisposition to the devastating condition. Right now, symptoms are almost 100% likely to develop in patients between the ages of 30 and 65.
Continue Reading
Category: Alzheimer's & Dementia, Brain Health, Body & Mind
Tags: Washington University School of Medicine, Alzheimer's disease, Dementia, Genetics, Brain, Cognitive functioning, Disease, clinical trials
http://dlvr.it/TJfzTf
Continue Reading
Category: Alzheimer's & Dementia, Brain Health, Body & Mind
Tags: Washington University School of Medicine, Alzheimer's disease, Dementia, Genetics, Brain, Cognitive functioning, Disease, clinical trials
http://dlvr.it/TJfzTf